130 related articles for article (PubMed ID: 27707005)
1. Genotoxicity of antiobesity drug orlistat and effect of caffeine intervention: an in vitro study.
Chakrabarti M; Ghosh I; Jana A; Ghosh M; Mukherjee A
Drug Chem Toxicol; 2017 Jul; 40(3):339-343. PubMed ID: 27707005
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of mutagenic effect of two antiobesity drugs on mice's genetic materials.
Ahmed S; Ghaly I
Drug Chem Toxicol; 2012 Oct; 35(4):445-9. PubMed ID: 22168402
[TBL] [Abstract][Full Text] [Related]
4. An
Kılıc M; Tuylu BA
Drug Chem Toxicol; 2020 Mar; 43(2):174-181. PubMed ID: 30052082
[TBL] [Abstract][Full Text] [Related]
5. Antiobesity drugs in early pregnancy and congenital malformations in the offspring.
Källén BA
Obes Res Clin Pract; 2014; 8(6):e571-6. PubMed ID: 25434912
[TBL] [Abstract][Full Text] [Related]
6. Can Spirulina maxima reduce the mutagenic potential of sibutramine?
Araldi RP; Santos NP; Mendes TB; Carvalho LB; Ito ET; de-Sá-Júnior PL; Souza EB
Genet Mol Res; 2015 Dec; 14(4):18452-64. PubMed ID: 26782493
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the genotoxic and cytotoxic effects of the anti-obesity drugs sibutramine and fenproporex.
da Silva CJ; dos Santos JE; Satie Takahashi C
Hum Exp Toxicol; 2010 Mar; 29(3):187-97. PubMed ID: 20051455
[TBL] [Abstract][Full Text] [Related]
8. Long-term pharmacotherapy for obesity and overweight.
Padwal R; Li SK; Lau DC
Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004
[TBL] [Abstract][Full Text] [Related]
9. Long-term persistence with orlistat and sibutramine in a population-based cohort.
Padwal R; Kezouh A; Levine M; Etminan M
Int J Obes (Lond); 2007 Oct; 31(10):1567-70. PubMed ID: 17420781
[TBL] [Abstract][Full Text] [Related]
10. In vitro genotoxicity evaluation of 4-carboxyl-2,6-dinitrophenylazohydroxynaphthalenes using human lymphocytes.
Adegoke OA; Kyu JK; Mukherjee A
Food Chem Toxicol; 2012 Mar; 50(3-4):936-41. PubMed ID: 22137901
[TBL] [Abstract][Full Text] [Related]
11. NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine.
Erondu N; Addy C; Lu K; Mallick M; Musser B; Gantz I; Proietto J; Astrup A; Toubro S; Rissannen AM; Tonstad S; Haynes WG; Gottesdiener KM; Kaufman KD; Amatruda JM; Heymsfield SB
Obesity (Silver Spring); 2007 Aug; 15(8):2027-42. PubMed ID: 17712121
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and determination of genotoxic effect of a novel dimeric 8-hydroxyquinoline Cd(II) SCN complex.
Tunca H; Berber AA; Çanakçi K; Tuna M; Yildiz SZ; Aksoy H
Drug Chem Toxicol; 2017 Jul; 40(3):300-308. PubMed ID: 27631679
[TBL] [Abstract][Full Text] [Related]
13. [Interaction of mutagens in binary mixtures using the alkaline comet assay in human lymphocytes].
Ortiz IC; Peláez CA; Orozco LY; Zuleta M
Biomedica; 2012 Sep; 32(3):437-48. PubMed ID: 23715192
[TBL] [Abstract][Full Text] [Related]
14. Gamma-hexalactone flavoring causes DNA lesion and modulates cytokines secretion at non-cytotoxic concentrations.
Zuravski L; Escobar TA; Schmitt EG; Amaral QDF; Paula FR; Duarte T; Duarte MMMF; Machado MM; Oliveira LFS; Manfredini V
BMC Pharmacol Toxicol; 2019 Dec; 20(Suppl 1):79. PubMed ID: 31852517
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the genotoxic effects of organophosphorus insecticides phorate and trichlorfon in human lymphocytes.
Timoroğlu İ; Yüzbaşıoğlu D; Ünal F; Yılmaz S; Aksoy H; Çelik M
Environ Toxicol; 2014 May; 29(5):577-87. PubMed ID: 22610949
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the mutagenic, recombinagenic and carcinogenic potential of orlistat in somatic cells of Drosophila melanogaster.
Orsolin PC; Silva-Oliveira RG; Nepomuceno JC
Food Chem Toxicol; 2012 Aug; 50(8):2598-604. PubMed ID: 22621838
[TBL] [Abstract][Full Text] [Related]
17. Long-term changes in blood pressure following orlistat and sibutramine treatment: a meta-analysis.
Johansson K; Sundström J; Neovius K; Rössner S; Neovius M
Obes Rev; 2010 Nov; 11(11):777-91. PubMed ID: 20025693
[TBL] [Abstract][Full Text] [Related]
18. Genotoxicity in lead treated human lymphocytes evaluated by micronucleus and comet assays.
Shah AJ; Lakkad BC; Rao MV
Indian J Exp Biol; 2016 Aug; 54(8):502-8. PubMed ID: 28577517
[TBL] [Abstract][Full Text] [Related]
19. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
[TBL] [Abstract][Full Text] [Related]
20. Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial.
Wadden TA; Berkowitz RI; Womble LG; Sarwer DB; Arnold ME; Steinberg CM
Obes Res; 2000 Sep; 8(6):431-7. PubMed ID: 11011909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
